Images List Premium Download Classic

Diabetes

Diabetes-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Biochemical markers for use in determining risk of diabetes
Wallac Oy
July 20, 2017 - N°20170205420

A method for predicting risk of gestational diabetes mellitus (gdm) in a pregnant individual includes measuring one or more biochemical markers in a blood sample obtained from the pregnant individual to determine one or more biomarker levels, where the one or more measured biochemical markers includes at least one of amylin, 17β-estradiol, and lipocalin-2, identifying, for each of ...
Goodpasture antigen binding protein detection and inhibition and its use in diabetes
Fibrostatin, S.l.
July 20, 2017 - N°20170204197

Disclosed herein are methods for treating type 2 diabetes, limiting development of type 2 diabetes, and treating a pre-diabetic state by administering to a subject in need thereof a gpbp inhibitor. Also disclosed herein are methods for diagnosing a pre-diabetic state and for diagnosing a propensity to develop type 2 diabetes by determining an amount of gpbp in a sample from a subject ...
Method of designing a peptide and/or peptide derivative for modulating gamma-c-cytokine activity
Bioniz, Llc
July 20, 2017 - N°20170204153

The γc-family cytokines, interleukin-2 (il-2), interleukin-4 (il-4), interleukin-7 (il-7), interleukin-9 (il-9), interleukin-15 (il-15), and interleukin-21 (il-21), are associated with important human diseases, such as leukemia, autoimmune diseases, collagen diseases, diabetes mellitus, skin diseases, degenerative neuronal diseases and graft-versus-host disease (gvhd). Thus, inhibitors of γc-cytokine activity are valuable therapeutic and cosmetic agents as well as research tools. ...
Diabetes Patent Pack
Download 521+ patent application PDFs
Diabetes Patent Applications
Download 521+ Diabetes-related PDFs
For professional research & prior art discovery
inventor
  • 521+ full patent PDF documents of Diabetes-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Adjusting insulin delivery rates
Bigfoot Biomedical, Inc.
July 20, 2017 - N°20170203038

A method may include delivering insulin, using an insulin pump and a controller, over a first diurnal time period based on a baseline basal insulin rate stored in memory. The controller may receive blood glucose data to control delivery of insulin via the insulin pump in amounts variable from the baseline basal insulin rate to control blood glucose levels for ...
Diabetes management system
Bigfoot Biomedical, Inc.
July 20, 2017 - N°20170203030

A variety of location-based and/or proximity-based features related to diabetes management systems can be used to improve maintenance compliance and/or to provide important information to pwd designated assistance entities (e. G., family, friends, givers, hcps, emergency medicine providers) under certain conditions. In some cases, a user's location can be tracked or determined to trigger and/or time alerts ...
Compositions comprising cyclocarya paliurus extract and preparation method and uses thereof
Infinitus (china) Company Ltd
July 20, 2017 - N°20170202897

Compositions and preparation method thereof, said compositions comprise an extract from a mixture comprising cyclocarya paliurus leaves and one or more herbs selected from the group consisting of mori cortex, dendrobii caulis and citri reticulatae pericarpium, said compositions can treat diabetes, hyperglycemia, hypertension and/or hyperlipidemia.
Diabetes Patent Pack
Download 521+ patent application PDFs
Diabetes Patent Applications
Download 521+ Diabetes-related PDFs
For professional research & prior art discovery
inventor
  • 521+ full patent PDF documents of Diabetes-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Biguanide compositions and methods of treating metabolic disorders
Elcelyx Therapeutics, Inc.
July 20, 2017 - N°20170202790

Provided herein are methods for treating certain conditions, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a biguanide or related heterocyclic compound, e. G., metformin. Also provided herein are biguanide or related heterocyclic compound compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein ...
User interface for diabetes management system
Bigfoot Biomedical, Inc.
July 13, 2017 - N°20170199985

A diabetes management system including a pump for dispensing a medicant and a control device for controlling the pump includes a user interface for controlling functions of the pump and providing information related to operation of the pump and other information. The user interface can display blood glucose information and insulin dosing data such that a user can appropriately act ...
Methods of treating diabetes and compositions capable of same
Ramot At Tel-aviv University Ltd.
July 13, 2017 - N°20170198021

A composition of matter is disclosed which comprises isolated oligomers of human islet amyloid polypeptide (iapp). Antibodies recognizing same are also disclosed. Use of the composition of matter and the antibodies are also disclosed.
Agonists of the apelin receptor and methods of use thereof
Sanford-burnham Medical Research Institute
July 13, 2017 - N°20170197958

Provided herein are small molecule agonists of the apelin receptor for the treatment of disease. The compounds disclosed herein are useful for the treatment of a range of cardiovascular, renal and metabolic conditions. The present invention is based on the seminal discovery of a series of potent small molecule agonists of the apelin receptor, which are useful for the treatment ...
Ultrashort peptides as exogenous second harmonic probes for bioimaging applications
Agency For Science, Technology And Research
July 13, 2017 - N°20170196993

Various aspects of the present invention relate to a peptide based biomaterial for visualization by shg microscopy. In particular the invention relates to the use of short peptides as a non-linear optical (nlo) material for second harmonic generation (shg) microscopy. A preferred short peptide comprises livagk (lk6) and contains a non-polar aliphatic tail (with decreasing hydrophobicity) and a polar head; ...
Composition for treating diabetes mellitus comprising insulin and a glp-1/ glucagon dual agonist
Hanmi Pharm. Co., Ltd.
July 13, 2017 - N°20170196943

A composition for preventing or treating diabetes mellitus includes insulin and a glp-1/glucagon dual agonist. The composition can inhibit the weight gain and reduce the danger of hypoglycemia due to the administration of insulin, lower the administration dose and greatly improve the compliance of drugs through a combined administration of a long-acting insulin conjugate and a long-acting glp-1/glucagon ...
Enhancement of glucose-stimulated insulin secretion by cells through induction of cellular senescence
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.
July 13, 2017 - N°20170196913

Methods for increasing glucose induced insulin secretion in an insulin secreting cell by inducing senescence in the cell are provided. Further, methods for treating diabetes, by providing cells with increased glucose induced insulin secretion to a subject, as well as a population of modified insulin secreting cells are provided.
Diabetes Patent Pack
Download 521+ patent application PDFs
Diabetes Patent Applications
Download 521+ Diabetes-related PDFs
For professional research & prior art discovery
inventor
  • 521+ full patent PDF documents of Diabetes-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Tgr5 agonist complexes for treating diabetes and cancer
City Of Hope
July 13, 2017 - N°20170196890

Provided herein are complexes of metformin or metformin analogues and a tgr5 ligand that are useful in treating diseases including diabetes, cardiovascular disease, and cancer.
Heterocyclic gsk-3 allosteric modulators
Consejo Superior De Investigaciones Cientificas (csic)
July 13, 2017 - N°20170196850

The present invention relates to heterocyclic substituted quinoline derivatives as allosteric inhibitors of the glycogen synthase kinase-3 (gsk-3) enzyme. Therefore, these compounds are useful for the manufacturing of a medicament designed for the treatment and/or prevention of diseases wherein gsk-3 is involved, such as neurodegenerative diseases, inflammatory diseases, cancer, diabetes, and to promote various regenerative processes.
Ex vivo browning of adipose tissue therapy for reversal of obesity and type ii diabetes
The Trustees Of Columbia University In The City Of New York
July 06, 2017 - N°20170191035

Provided are methods, apparatus, pharmaceutical compositions, and kits for treatment of a metabolic condition, including obesity and type 2 diabetes, by administration to a subject of a therapeutically effective amount of a cell or tissue preparation such as brown adipose microtissues or brown adipose tissue directly converted from white adipose tissue. Modified approaches to creating brown adipose tissue involve differentiation of ...
Compositions for selective reduction of circulating bioactive soluble tnf and methods for treating tnf-mediated disease
Thymon, Llc
July 06, 2017 - N°20170190768

An isolated or synthetic antibody or ligand is provided that specifically binds to an epitope of a dissociated monomer of human tnf. Such binding disrupts assembly of the monomer into bioactive trimeric human stnf. A pharmaceutical composition contains one or more antibodies or ligands: (a) an antibody or ligand that specifically binds the tnf monomer-specific epitope having the sequence psdkpvah ...
Alpha1 -antitrypsin compositions and methods of treating autoimmune diseases
Beth Israel Deaconess Medical Center, Inc.
July 06, 2017 - N°20170190762

The specification provides compositions comprising chimeric proteins comprising aat conjugated to an fc region of an immunoglobulin. Methods for treating autoimmune disease, e. G., diabetes, e. G., type 1 and type 2 diabetes, are also provided.
Novel glucagon analogues
Novo Nordisk A/s
July 06, 2017 - N°20170190757

The present invention relates to novel peptide compounds which have a protracted profile of action and improved solubility and stability, to the use of the compounds in therapy, to methods of treatment comprising administration of the compounds to patients in need thereof, and to the use of the compounds in the manufacture of medicaments. The compounds of the invention are ...
Pyridine derivative
Teijin Pharma Limited
July 06, 2017 - N°20170190694

Provided is a pyridine derivative represented by formula (i), a prodrug thereof, a pharmaceutically acceptable salt of the pyridine derivative or the prodrug, or a solvate of the pyridine derivative, the prodrug or the pharmaceutically acceptable salt, which is useful for treatment or prophylaxis of diseases associated with urat1 such as gout, hyperuricemia, hypertension, kidney diseases such as interstitial nephritis, ...
Exendin-4 analogue pegylated with polyethylene glycol or derivative thereof, preparation method thereof, and pharmaceutical composition ...
Theraly Pharmaceuticals Inc.
July 06, 2017 - N°20170189545

The present disclosure relates to an exendin-4 analogue pegylated with polyethylene glycol or a derivative thereof, a preparation method, and a pharmaceutical composition for prevention or treatment of diabetes containing the same as an active ingredient. According to the present invention, the yield of an exendin-4 analogue can be increased via the selective pegylation by using exendin-4 in which a ...
Loading